Todd Callister

Todd Callister is a Nashville-based finance executive who spent most of his investment career as Chief Financial Officer of MedCare Investment Funds, a Nashville, Tennessee private equity and venture firm founded in 1991 that specializes in the medical and healthcare-services sectors. Public records place his tenure at MedCare from roughly November 2009 to December 2018, where he held the roles of Managing Director, CFO, and Vice President. During that period MedCare and its affiliated entities managed approximately $1 billion in assets, the substantial majority tied to healthcare, across a portfolio of about fifteen companies spanning services, information technology, medical devices, pharmaceuticals, and biotechnology.

At MedCare, Callister was a public-facing member of leadership. In a 2012 firm announcement naming a new Chief Information Officer, he spoke on behalf of the fund about how MedCare evaluates and supports the IT strategy of its portfolio companies. He is credited with playing a significant role in MedCare's multi-round investment in Gradalis, a clinical-stage biotech, and with helping oversee the fund's direct investments and exits.

Since leaving MedCare, Callister has worked as a fractional and strategic CFO. He founded Callister Consulting (from January 2019), positioning himself as a "strategic CFO and thought partner to CEOs" serving healthcare venture-studio and private-equity clients, and he has more recently been listed as a Business Consultant at Crossfire Consulting (from 2024). Across his career he describes having managed 20+ direct investments and helped facilitate more than $1.2 billion in exit transactions. He completed executive education at Harvard Business School (2021) and describes himself professionally as a "calm navigator" strong in strategy, operations, people, and process. He is active in the Franklin, Tennessee community, where he has served in lay leadership (including as a bishop) in The Church of Jesus Christ of Latter-day Saints.

• Sector: Healthcare and medical services above all — the defining mandate of MedCare Investment Funds across services, health IT, devices, pharma, and biotech.
• Stage: Broad but early-weighted — MedCare has been described as investing across seed, start-up, early-, mid-, and late-venture financing, consistent with the "seed round" angle in the stub data.
• Approach: MedCare historically made concentrated, multi-round bets and stayed involved operationally, evaluating and shaping portfolio companies' use of technology and finance (as Callister described in the firm's own CIO announcement).
• Founder-facing value: Callister's own positioning is as a finance/operations partner to CEOs — someone who "synthesizes financial analysis with operational insights" to help companies scale and reach exits, rather than a purely passive capital source.